Our staff of former FDA and EU officials as well as Industry experts allows us to combine global regulatory knowledge with industry best practices to help our clients achieve a compliant quality system that is right for their business. Our team has extensive experience in the development, marketing, and international regulation of medical device products, and a proven record of achieving client success.
Elaine Messa, RAC, FRAPS - President, Health Sciences Medical Devices
Elaine Messa has over 30 years of experience in FDA regulation of medical devices, focused on the development and implementation of compliant quality systems for medical devices in the United States and abroad. Her most recent position at FDA was Director of the Los Angeles District. Ms. Messa has significant experience in auditing, agency communication, development of quality systems, and design and implementation of corrective action plans to address complex compliance situations including consent decrees, Corporate Integrity Agreements, warning letters and 483s. Ms. Messa was previously the Executive Vice President of Becker & Associates Consulting, where she oversaw the quality systems and compliance consulting services for Becker Consulting’s medical devices practice.
Mary C. Getz, Ph.D. - Vice President, Quality Systems & Compliance
Mary Getz has over 25 years of industry experience, including extensive expertise in developing quality, compliance and regulatory affairs strategies and solutions. She has helped domestic and international manufacturers to develop and implement comprehensive compliance action plans. The results were effective quality systems which lead to successful FDA and notified body inspections as well as NDA and PMA product approvals. Dr. Getz has hands-on experience with IVDs, 510(k) and PMA medical devices, as well as OTC and NDA pharmaceuticals. She has held vice president-level roles in quality and regulatory affairs at numerous multinational companies in the healthcare sector. Dr. Getz was previously the Director of Quality Systems and Compliance at Becker & Associates Consulting.
Kristen Grumet - Executive Director, Quality Systems
Kristen Grumet has over 25 years of experience including nine years at FDA as a Field Investigator specializing in the area of medical devices, and 16 years working and consulting for medical device companies in quality systems compliance. At FDA, Ms. Grumet served on the Design Control Inspection Strategy (DCIS) and Pacific Region Design Control Training Cadre teams to develop, implement and train industry on the use of the DCIS questionnaire in FDA medical device inspections. She was a Phase II certified performance auditor and a member of the first FDA cadre of certified medical device investigators. She conducted numerous medical device inspections in Europe with the FDA foreign inspection cadre, and has managed successful third-party certifications for companies under FDA consent decree.
Meaghan Bailey, RAC - Senior Director
Meaghan Bailey’s expertise is in the analysis of complex regulatory challenges, and her consulting supports the development and compliant marketing of innovative medical devices. She advises life science companies on regulatory strategies, prepares regulatory submissions, conducts literature reviews and other analyses, and provides assistance with preclinical and clinical programs. Ms. Bailey has particular expertise in preparing sponsors for Medical Devices Advisory Committee panel meetings, and in supporting other premarket FDA interactions on behalf of a sponsor. Ms. Bailey has supported the development and commercialization of a wide variety of products including in vitro diagnostics, devices for the treatment of women’s health issues and diabetes management devices. Ms. Bailey was previously a Managing Director for Innovative Healthcare Products at Becker & Associates Consulting.
James Pink – Vice President, Europe, NSF Health Sciences Medical Devices
James Pink has 17 years of experience in the medical devices industry including 10 years as a healthcare technology expert and lead auditor for a leading European notified body. His industry experience includes managing development and quality assurance programs for orthopedic, cardiovascular, wound and combination products. Mr. Pink has a team of experts based in Europe who have over 20 years’ individual experience in both competent authority and notified body leadership. He has coordinated and presented to EU competent authorities and expert working groups relating to classification decisions, clinical study design, scientific and technical briefings, and EU remediation strategies.
Greg Openshaw – Head of Training & Education
Greg Openshaw has 16 years’ operations and project management experience in the financial and health science industries. He is primarily responsible for the initiation of consulting, training and auditing programs, ensuring financial, operational and logistical activities are planned in line with our clients’ needs. His industry experience includes the development of global company learning and competency academies facilitating the development of specific training, education and qualification programs for various disciplines across highly regulated areas. Holding qualifications in senior management and human resource development, Mr. Openshaw is highly involved in the management of our Qualified Person program as well as our professional certification and post-graduate qualifications.
Alastair Selby, Ph.D. - Regulatory Science Consultant
Alastair Selby has been working in the medical device industry as a regulatory science specialist for three years. Working prior to that in academia, he uses his background in biomedical materials science to add theoretical and technical expertise to the NSF Medical Devices team.
Dr. Selby has successfully written and contributed to multiple regulatory science documents and submissions, including clinical evaluations to EN ISO 14155 & SG5/N2R8, risk management files to EN ISO 14971, biological evaluations to EN ISO 10993, design history files, human factors and usability studies, and clinical investigation applications.
Ronald M. Johnson - Expert Consultant
Ron Johnson has more than 30 years of senior FDA leadership experience as well as 14 years of applied consulting practice assisting FDA-regulated companies with complex regulatory and compliance matters, particularly in the field of medical device compliance and quality systems. Through numerous senior FDA management positions at the district office level and at the Center for Devices and Radiological Health (CDRH), and experience as a trusted advisor to industry, both as a consultant and a valued board member for pharmaceutical corporations, Mr. Johnson has developed a uniquely multi-faceted perspective on regulatory and compliance issues.
Mr. Johnson’s wide ranging experience and resulting intimate understanding of FDA regulatory and compliance issues from the perspective of both FDA and regulated industry enable him to develop and execute strategic, timely solutions for industry that both meet current client needs and anticipate potential future issues. Mr. Johnson previously served as President of Becker & Associates Consulting.
Timothy Ulatowski - Expert Consultant
Timothy Ulatowski has over 36 years of public health experience, including more than 20 years in multiple leadership positions at FDA’s Center for Devices and Radiological Health (CDRH). He most recently served as Director of the Office of Compliance at CDRH, where he managed and supervised four divisions responsible for ensuring compliance with medical device regulations. Mr. Ulatowski has proven expertise in advising industry on regulatory issues, assessing compliance and enforcement actions, evaluating premarket documents, and resolving complex technical and scientific problems.
Harold “Wally” Pellerite - Expert Consultant
Wally Pellerite helps guide the development of NSF’s medical device compliance practice in addition to providing technical consulting solutions for clients. He is the former Director of Strategic Compliance at Quintiles Consulting in Maryland, where he applied his significant experience with regulatory requirements for medical devices and experience in evaluating and resolving compliance and enforcement issues. From his 30 year career within FDA’s Center for Devices and Radiological Health (CDRH), Mr. Pellerite has an extensive historical knowledge of FDA enforcement strategies, policies, and actions. He works with clients to develop and execute cost-effective gap analyses and corrective action plans in response to FDA 483s, Warning Letters, and other regulatory actions. He is recognized as an expert in the Medical Device area and has served as an expert witness in numerous civil cases.
Steve Yost - Principal Consultant
Steve Yost has over 13 years of experience in FDA regulated industry, primarily in medical device manufacturing. He has served as an FDA Consumer Safety Officer in the Office of Regulatory Affairs, receiving numerous awards for outstanding performance, including a nomination for the Patrick J. Poulzer National Investigator of the Year Award. His efforts since leaving FDA have focused on the development and implementation of quality systems for the medical device industry in the US and abroad, as well as the creation and submission of 510(k)s and PMAs. He has also held various management positions in quality and regulatory departments at medical device, IVD, and human cellular and tissue product manufacturers. Steve’s areas of expertise include auditing, audit preparation such as mock FDA audits, quality system remediation, regulatory submissions and the development of responses to warning letters and FDA 483s.
James R. Scull, Ph.D. - General Manager, NSF Heath Sciences
James R. Scull has more than 27 years of pharmaceutical development experience spanning all areas from discovery support to Phase III clinical trials. His current responsibilities include providing strategic scientific and technical leadership with a global perspective to NSF's Health Sciences Division. Dr. Scull is focused on providing clients with technical expertise and project management designed to accelerate the drug development process. Dr. Scull's primary expertise is in the areas of GLP analytical chemistry, formulation, compliance and separation science. He is also an expert in conducting extractables and leachables studies and oligonucleotide analysis. Prior to joining NSF Health Sciences, Dr. Scull served as Executive Director of Pharmalytica Services, LLC, Principal Research Scientist for the DuPont Pharmaceutical Company and GLP Outsourcing Manager for Purdue Pharma. Dr. Scull holds a Ph.D. in analytical chemistry from Villanova University.
Richard C. Wedlich, M.S. - Director of Quality Assurance, NSF Heath Sciences
Richard C. Wedlich has more than 30 years of R&D experience in the pharmaceutical, chemical and aerospace industries. Prior to joining NSF Health Sciences, Mr. Wedlich was Principal and Co-Founder of Pharmalytica Services, LLC, where he served as Vice President and Executive Director of Quality Assurance and Regulatory Affairs for over 10 years. He has also held the positions of Senior Engineer at the Schering-Plough Research Institute, Senior Process Safety Specialist at Chilworth Technologies, Senior Research Chemist at Olin Corporation, Scientist at Lockheed Engineering, Management and Sciences Company (NASA WSTF) and Chemist at Organon Pharmaceuticals. Mr. Wedlich has published numerous peer-reviewed, scientific articles. He holds a Bachelor of Science degree in chemistry from Ramapo College of New Jersey and a Master of Science degree in chemistry from Marquette University.
Kurt L. Moyer, Ph.D. - Director of Research, NSF Health Sciences
Kurt L. Moyer has more than 23 years of pharmaceutical development experience spanning all areas from discovery support to marketed products. His primary expertise is in the areas of bioanalysis, extractables and leachables, method development and validation, identification of impurities and metabolites, and GLP/GMP compliance. He also has extensive experience with drugs for anticoagulant and cardiovascular therapies. In addition, Dr. Moyer provides NSF Health Sciences clients with project management that is designed to accelerate the development process. Prior to joining NSF Health Sciences, Dr. Moyer served as a Senior Research Investigator for Sanofi Aventis and a Research Scientist for the DuPont Pharmaceutical Company. Dr. Moyer received his Ph.D. in biochemistry from Villanova University.
- 4 days ago
FDA Regulatory and Compliance News FDA announced the availability of a guidance for industry entitled, “Analytical Procedures and Methods Validation...
- 2 weeks ago
FDA Regulatory and Compliance News FDA announced the availability of a revised draft guidance for industry entitled, “Bioequivalence Recommendations for...
- 6 months ago
By Kristen Grumet. Posted in Regulatory and Compliance by MDDI Staff
- Wednesday, September 16, 2015
- 9:00am - 5:00pm GMT
- Sheffield , United Kingdom
- Wednesday, October 7, 2015
- 8:30am - 5:00pm GMT
- Sheffield , United Kingdom